SAvvyWire™ EFficacy & SafEty in Transcatheter Aortic Valve Implantation

See also
Status	Clinical Trial	Phase
Completed	`NCT01238497` - SOURCE XT REGISTRY
Recruiting	`NCT04029844` - Colibri Transcatheter Aortic Heart Valve System Study	N/A
Recruiting	`NCT03280433` - Influence of EPICardial Adipose Tissue in HEART Diseases: EPICHEART Study	N/A
Active, not recruiting	`NCT03752866` - The CONFIDENCE Registry	N/A
Completed	`NCT01651780` - Open-label, Randomized Trial in Patients Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH	Phase 3
Recruiting	`NCT06173115` - Comparison of a Single Versus Double Perclose Technique for TAVR	N/A
Recruiting	`NCT06136429` - A Prospective, Multicenter, Single-arm Study to Evaluate a Transcatheter Aortic Valve System Safety and Efficacy for the Treatment of Patients With Severe Aortic Stenosis	N/A
Not yet recruiting	`NCT06015997` - Prevalence of ATTR Cardiac Amyloidosis in Patients Undergoing TAVR
Recruiting	`NCT03291925` - Primary Non-invasive Cardiac Computed Tomography Versus Routine Invasive Angiography Prior to TAVI	N/A
Terminated	`NCT03004599` - Safety and Efficacy of SYM-SV/DS-002 in Patients With Severe Aortic Stenosis	N/A
Recruiting	`NCT04076150` - Safety and Performance Study of the Optimum Transcatheter Aortic Valve	N/A
Completed	`NCT01074658` - CoreValve Advance International Post Market Study	N/A
Completed	`NCT02575768` - Myocardial Flow Reserve in Severe AS Without Obstructive Coronary Artery Disease	N/A
Completed	`NCT01994330` - Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery	Phase 4
Completed	`NCT04286893` - Improved HRV, Inflammation Markers and Endothelial Function After TAVI
Not yet recruiting	`NCT06177392` - VARC-TAVI VALVE IMPLANTATION)	N/A
Active, not recruiting	`NCT04206228` - Intravenous Iron Supplement for Iron Deficiency in Patients With Severe Aortic Stenosis	Phase 2
Not yet recruiting	`NCT03788590` - Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System	N/A
Completed	`NCT01531374` - Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement	N/A
Recruiting	`NCT05493657` - Aspirin vs Clopidogrel After TAVR	N/A

NCT number	NCT05492383
Study type	Interventional
Source	Opsens, Inc.
Contact
Status	Completed
Phase	N/A
Start date	October 25, 2022
Completion date	March 3, 2023

SAvvyWire™ EFficacy and SafEty in Transcatheter Aortic Valve Implantation Procedures (SAFE-TAVI) — SAFE-TAVI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms